- Article
- Published:
Anti-platelet effect of ginkgolide a from Ginkgo biloba
Journal of the Korean Society for Applied Biological Chemistry volume 57, pages 221–228 (2014)
Abstract
Effects of ginkgolide A (GA) from Ginkgo biloba leaves in collagen (10 μg/mL)-stimulated platelet aggregation were investigated. Zymographic analysis confirmed that pro-matrix metalloproteinase-9 (MMP-9) (92 kDa) was activated by GA to form an activated MMP-9 (86-kDa) on gelatinolytic activities. GA concentration-dependently inhibited platelet aggregation, intracellular Ca2+ mobilization, and thromboxane A2 (TXA2) formation by inhibiting the cyclooxygenase-1 (COX-1) activity in collagen-stimulated platelets. In addition, GA increased the formation of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), which have an anti-platelet function in both resting and collagen-stimulated platelets. On the other hand, GA did not prolong prothrombin time (PT) and activated partial thromboplastin time (aPTT) associated with the extrinsic and intrinsic coagulation pathways on human plasma, respectively. Therefore, we suggest that the inhibitory effect of GA on platelet aggregation might involve the following pathway. GA may increase the MMP-9 activity and intracellular cAMP and cGMP production, inhibit intracellular Ca2+ mobilization, and decrease TXA2 production by down-regulating the COX-1, thereby leading to inhibition of platelet aggregation without cytotoxicity. These results strongly indicate that GA is a potent inhibitor of collagen-stimulated platelet aggregation. It may play an important role as a negative regulator during platelet activation.
References
Agnoli A, Rapin JR, Scapagnini V, and Weitbrecht WV (1984) In Effects of Ginkgo biloba Extract on Oraganic Cerebral Impairement, (4th ed), John Libbey & Co Ltd, London.
Braquet P (1986) Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L. Adv Prost Res 26, 179–198.
Brikedal-Hansen H (1995) Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7, 728–735.
Cattaneo M, Tenconi PM, Lecchi A, and Mannucci PM (1991) In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. Thromb Res 62, 717–724.
Charo IF, Feinman RD, and Detwiler TC (1977) Interrelations of platelet aggregation and secretion. J Clin Invest 60, 866–873.
Cho HJ and Nam KS (2007a) Inhibitory effect of ginkgolide B on platelet aggregation in a cAMP-and cGMP-dependent manner by activated MMP-9. J Biochem Mol Biol 40, 678–683.
Cho HJ, Ham HS, Lee TK, Jung YJ, Choi SA, Kang HC et al. (2004) Inhibitory effect of cordycepin on human platelet aggregation. J Biomed Lab Sci 10, 1–8.
Cho HJ, Shon YH, and Nam KS (2007b) Ginkgolide C inhibits platelet aggregation in cAMP- and cGMP-dependent manner by activating MMP-9. Biol Pharm Bull 30, 2340–2344.
Direu K and De Feudis FV (2000) In Ginkgo biloba: Chap 17, (1st ed), Harwood Academic Publishers, Netherlands.
Homer KL and Wanstall JC (2002) Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate. Br J Pharmacol 137, 1071–1081.
Jang EK, Azzam JE, Dickinson NT, Davidson MM, and Haslam RJ (2002) Roles for both cyclic GMP and cyclic AMP in the inhibition of collageninduced platelet aggregation by nitroprusside. Br J Haematol 117, 664–675.
Kaibuchi K, Sano K, Hoshijima M, Takai Y, and Nishizuka Y (1982) Phosphatidylinositol turnover in platelet activation; calcium mobilization and protein phosphorylation. Cell Calcium 3, 323–335.
Karcher L, Zagermann P, and Krieglstein J (1984) Effect of an extract of Ginkgo biloba on rat brain energy metabolism in hypoxia. Naunyn Schmiedebergs Arch Pharmacol 27, 31–35.
Kinsella BT, O’Mahony DJ, and FitzGerald GA (1994) Phosphorylation and regulated expression of the human thromboxane A2 receptor. J Biol Chem 269, 29914–29919.
Kleijnen J and Knipschild P (1992) Ginkgo biloba. Lancet 340, 1136–1139.
Komalavilas P and Lincoln TM (1994) Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic GMP-dependent protein kinase. J Biol Chem 269, 8701–8707.
Kratz A and Lewandrowski KB (1998) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values. N. Engl. J. Med 339, 1063–1072.
Menshikov MYu, Ivanova K, Schaefer M, Drummer C, and Gerzer R (1993) Influence of the cGMP analog 8-PCPT-cGMP on agonist-induced increases in cytosolic ionized Ca2+ and on aggregation of human platelets. Eur J Pharmacol 245, 281–284.
Nishikawa M, Tanaka T, and Hidaka H (1980) Ca2+-calmodulin-dependent phosphorylation and platelet secretion. Nature 287, 863–865.
Pagana KD and Pagana PJ (2010) Mosby’s manual of diagnostic and laboratory tests. Mosby Elsevier, St. Louis, 396–397, 448–449.
Park WH, Kim HK, Nam KS, Shon YH, Jeon BH, Moon SK et al. (2004) Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets. Life Sci 75, 3063–3076.
Pasqui AL, Capecci PL, Ceccatelli L, Mazza S, Gistri A, and Laghi Pasini F (1991) Nitroprusside in vitro inhibits platelet aggregation and intracellular calcium translocation. Effect of hemoglobin. Thromb Res 61, 113–122.
Qi R, Ozaki Y, Satoh K, Yang LB, Asazuma N, and Yatomi Y (1996) Intracellular levels of cyclic AMP and cyclic GMP differentially modify platelet aggregate size in human platelets activated with epinephrine or ADP. J Cardiovasc Pharmacol 28, 215–225.
Ray JM and Stetler-Stevenson WG (1994) The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 7, 2062–2072.
Rivera J, Lozano ML, Navarro-Nunez L, and Vicente V (2009) Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica 94, 700–711.
Rodomski MW, Palmer RMJ, and Monacade S (1990) An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proceedings Proc Natl Acad Sci USA 87, 5193–5197.
Sawicki G, Salas E, Murat J, Miszta-Lane H, and Radomski MW (1997) Release of gelatinase A during platelet activation mediates aggregation. Nature 386, 616–618.
Schaeffer J and Blaustein MP (1989) Platelet free calcium concentrations measured with fura-2 are influenced by the transmembrane sodium gradient. Cell Calcium 10, 101–103.
Schwartz SM, Heinmark RL, and Majesky MW (1990) Developmental mechanisms underlying pathology of arteries. Physiol Rev 70, 1177–1209.
Sheu JR, Fong TH, Liu CM, Shen MY, and Chen TL (2004) Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. Br J Pharmacol 143, 193–201.
Sudo T, Ito H, and Kimura Y (2003) Phosphorylation of the vasodilatorstimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets. Platelets 14, 381–390.
Tang W and Eisenbrand G (1992) In Chinese Drugs of Plant Origin, (1st ed), Springer Verlag, Germany.
Van Beek TA (2000a) In Ginkgo biloba: Chap 1, (1st ed), Harwood Academic Publishers, Netherlands.
Van Beek TA (2000b) In Ginkgo biloba: Chap 7, (1st ed), Harwood Academic Publishers, Netherlands.
Wang RG, Zhu Y, Halushka PV, Lincoln TM, and Mendelsohn ME (1998) Mechanism of platelet inhibition by nitric oxide: In vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci USA 95, 4888–4893.
Author information
Authors and Affiliations
Corresponding author
Additional information
Jin-Hyeob Ryu and Ju-Ye Ro contributed equally to this work.
Rights and permissions
About this article
Cite this article
Ryu, JH., Ro, JY., Park, HJ. et al. Anti-platelet effect of ginkgolide a from Ginkgo biloba . J Korean Soc Appl Biol Chem 57, 221–228 (2014). https://doi.org/10.1007/s13765-013-4275-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13765-013-4275-2